Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrative Genetic, Molecular and Behavioural Determinants of Cognitive Decline in Type 2 Diabetes: SGLT2 Inhibitors as a Model for Secondary and Tertiary Prevention (SaveMinD)

NCT07694596 is registered in ClinicalTrials.gov with University of Primorska as lead sponsor.

NCT NCT07694596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07694596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrative Genetic, Molecular and Behavioural Determinants of Cognitive Decline in Type 2 Diabetes: SGLT2 Inhibitors as a Model for Secondary and Tertiary Prevention (SaveMinD)
Lead sponsor
University of Primorska
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 20, 2026
Completion date
April 20, 2028
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive dysfunction, type 2 diabetes mellitus (t2dm)